Catheter Competitors
| VTAK Stock | 1.94 0.14 6.73% |
Catheter Precision vs WORK Medical Correlation
Modest diversification
The correlation between Catheter Precision and WOK is 0.2 (i.e., Modest diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Catheter Precision and WOK in the same portfolio, assuming nothing else is changed.
Catheter Precision Competition Correlation Matrix
Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Catheter Precision and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of Catheter and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Catheter Precision does not affect the price movement of the other competitor.
High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Catheter Stock performing well and Catheter Precision Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Catheter Precision's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| TIVC | 4.89 | (1.12) | 0.00 | (0.44) | 0.00 | 10.43 | 46.76 | |||
| NIVF | 7.40 | (3.33) | 0.00 | (1.77) | 0.00 | 15.95 | 44.03 | |||
| HSCS | 4.27 | 0.15 | 0.02 | (1.80) | 5.06 | 11.07 | 26.18 | |||
| BBLG | 3.32 | (0.37) | 0.00 | (0.27) | 0.00 | 6.84 | 22.82 | |||
| CERO | 10.30 | (1.76) | 0.00 | (1.05) | 0.00 | 20.00 | 94.69 | |||
| ISPC | 5.65 | (1.16) | 0.00 | (0.29) | 0.00 | 11.54 | 37.80 | |||
| ELAB | 4.78 | (2.68) | 0.00 | (1.17) | 0.00 | 5.71 | 38.62 | |||
| GLMD | 4.10 | (0.90) | 0.00 | (0.87) | 0.00 | 8.04 | 21.39 | |||
| UPC | 4.56 | 0.03 | 0.00 | 0.06 | 5.32 | 13.75 | 52.35 | |||
| WOK | 10.88 | (3.47) | 0.00 | 2.00 | 0.00 | 20.48 | 121.00 |
Cross Equities Net Income Analysis
Compare Catheter Precision and related stocks such as Tivic Health Systems, NewGenIvf Group, and Heart Test Laboratories Net Income Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| TIVC | (4.1 M) | (4.1 M) | (4.1 M) | (4.1 M) | (4.1 M) | (4.1 M) | (4.1 M) | (4.1 M) | (4.1 M) | (4.1 M) | (3.6 M) | (8.5 M) | (10.1 M) | (8.2 M) | (5.7 M) | (5.1 M) | (5.3 M) |
| NIVF | (533) | (533) | (533) | (533) | (533) | (533) | (533) | (533) | (533) | (533) | (533) | (533) | 458.7 K | (690.9 K) | (525 K) | (472.5 K) | (448.9 K) |
| HSCS | (3.8 M) | (3.8 M) | (3.8 M) | (3.8 M) | (3.8 M) | (3.8 M) | (3.8 M) | (3.8 M) | (3.8 M) | (3.8 M) | (2.5 M) | (4.8 M) | (6.4 M) | (6.6 M) | (8.8 M) | (7.9 M) | (8.3 M) |
| BBLG | (13.3 K) | (715) | (715) | (1.1 M) | (4.4 M) | (13.9 M) | (25.9 M) | (7.1 M) | (4.4 M) | (3.4 M) | (1.8 M) | (1.6 M) | (1.5 M) | (8.9 M) | (4.1 M) | (3.7 M) | (3.9 M) |
| CERO | (315.5 K) | (315.5 K) | (315.5 K) | (315.5 K) | (315.5 K) | (315.5 K) | (315.5 K) | (315.5 K) | (315.5 K) | (315.5 K) | (315.5 K) | (315.5 K) | (667.7 K) | (2.5 K) | (7.7 M) | (7 M) | (6.6 M) |
| ISPC | (5.3 M) | (5.3 M) | (5.3 M) | (5.3 M) | (5.3 M) | (5.3 M) | (5.3 M) | (5.3 M) | (5.3 M) | (4.7 M) | (4.7 M) | (9 M) | (10.2 M) | (11.1 M) | (12.5 M) | (11.2 M) | (11.8 M) |
| ELAB | (222.9 K) | (222.9 K) | (222.9 K) | (222.9 K) | (222.9 K) | (222.9 K) | (222.9 K) | (222.9 K) | (222.9 K) | (222.9 K) | (222.9 K) | (784.7 K) | (1.8 M) | (4.3 M) | (6.2 M) | (5.6 M) | (5.3 M) |
| GLMD | (3.1 M) | (3.1 M) | (3.1 M) | (17.5 M) | (9.1 M) | (10.6 M) | (17 M) | (12.3 M) | (9.9 M) | (18.5 M) | (27.6 M) | (31.9 M) | (18.6 M) | (6.9 M) | (7.5 M) | (6.8 M) | (7.1 M) |
| UPC | 7.6 M | 7.6 M | 7.6 M | 7.6 M | 7.6 M | 7.6 M | 7.6 M | 7.6 M | 7.6 M | 7.6 M | 11.3 M | (8.7 M) | (6.2 M) | (8.7 M) | (3.7 M) | (3.3 M) | (3.1 M) |
| WOK | 1.2 M | 1.2 M | 1.2 M | 1.2 M | 1.2 M | 1.2 M | 1.2 M | 1.2 M | 1.2 M | 1.2 M | 6 M | 865.2 K | 112 K | (3.5 M) | (3.5 M) | (3.1 M) | (3 M) |
Catheter Precision and related stocks such as Tivic Health Systems, NewGenIvf Group, and Heart Test Laboratories Net Income description
Net income is one of the most important fundamental items in finance. It plays a large role in Catheter Precision financial statement analysis. It represents the amount of money remaining after all of Catheter Precision operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.Catheter Precision Competitive Analysis
The better you understand Catheter Precision competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Catheter Precision's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Catheter Precision's competition over several years is one of the best ways to analyze its investment potential.| Better Than Average | Worse Than Peers | View Performance Chart |
Catheter Precision Competition Performance Charts
Five steps to successful analysis of Catheter Precision Competition
Catheter Precision's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Catheter Precision in relation to its competition. Catheter Precision's competition analysis typically involves several steps, including:- Identifying the key players in the market: This involves identifying the major competitors of Catheter Precision in the market, both direct and indirect, as well as new entrants and disruptive technologies.
- Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
- Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Catheter Precision's competitive landscape.
- Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Catheter Precision, and developing a strategy to address them.
- Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Complement your Catheter Precision position
In addition to having Catheter Precision in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Convertibles Funds Thematic Idea Now
Convertibles Funds
Funds or Etfs that invest in debt that is expected to be converted into a predetermined amount of the company equity at some future date. The Convertibles Funds theme has 26 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Convertibles Funds Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Catheter Precision Correlation with its peers. For more information on how to buy Catheter Stock please use our How to buy in Catheter Stock guide.You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Catheter Precision. If investors know Catheter will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Catheter Precision assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Earnings Share 33.63 | Revenue Per Share | Quarterly Revenue Growth 1.28 | Return On Assets | Return On Equity |
The market value of Catheter Precision is measured differently than its book value, which is the value of Catheter that is recorded on the company's balance sheet. Investors also form their own opinion of Catheter Precision's value that differs from its market value or its book value, called intrinsic value, which is Catheter Precision's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Catheter Precision's market value can be influenced by many factors that don't directly affect Catheter Precision's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Catheter Precision's value and its price as these two are different measures arrived at by different means. Investors typically determine if Catheter Precision is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Meanwhile, Catheter Precision's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.